This Article Full Text Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Olivecrona, G. Articles by Beisiegel, U. Search for Related Content PubMed PubMed Citation Articles by Olivecrona, G. Articles by Beisiegel, U.

(Arteriosclerosis, Thrombosis, and Vascular Biology. 1997;17:1545-1549.)
© 1997 American Heart Association, Inc.

Articles

Lipid Binding of Apolipoprotein CII Is Required for Stimulation of Lipoprotein Lipase Activity Against Apolipoprotein CII–Deficient Chylomicrons

Gunilla Olivecrona; ; Ulrike Beisiegel

From the Department of Medical Biochemistry and Biophysics, Umeå University, Umeå, Sweden (G.O.), and the Department of Medicine, University Hospital Eppendorf, Hamburg, Germany (U.B.).

Correspondence to Gunilla Olivecrona, Department of Medical Biochemistry and Biophysics, Umeå University, S-901 87 Umeå, Sweden. E-mail Gunilla.Olivecrona{at}medchem.umu.se

Abstract Human apolipoprotein CII (apo CII) consists of 79 amino acid residues. The amino-terminal two thirds of the molecule binds to lipid through the formation of amphipathic helixes, while the carboxy-terminal third is engaged in activation of lipoprotein lipase (LPL). On the basis of studies in model systems, it was previously concluded that fragments of apo CII spanning residues 51-79 were sufficient for activation, although they do not bind to lipid. In the present study, we used chylomicrons from an apo CII–deficient patient to reinvestigate this possibility, with a physiologically relevant substrate. Human LPL expressed very low activity against these chylomicrons. Addition of apo CII caused an immediate >100-fold increase in lipase activity. The apo CII fragment 50-79 caused very little stimulation, though with some synthetic lipid substrates, this fragment was fully effective. LPL bound to the chylomicrons even in the absence of apo CII but apparently in a nonproductive manner. In accord with this finding, the main effect of apo CII was on the V_MAX for the reaction, with little or no change in the apparent K_M. We conclude that the lipid-binding part of apo CII is needed for activity of LPL against chylomicrons. This idea is in accord with previous studies with lipid monolayers, which showed that the lipid-binding part is necessary for activation of the enzyme at high surface pressures.

Key Words: apolipoprotein CII • lipoprotein lipase • chylomicrons • lipid binding

This article has been cited by other articles:

				W. K. Sonnenburg, D. Yu, E-C. Lee, W. Xiong, G. Gololobov, B. Key, J. Gay, N. Wilganowski, Y. Hu, S. Zhao, et al. GPIHBP1 stabilizes lipoprotein lipase and prevents its inhibition by angiopoietin-like 3 and angiopoietin-like 4 J. Lipid Res., December 1, 2009; 50(12): 2421 - 2429. [Abstract] [Full Text] [PDF]

				H. Kondo, Y. Minegishi, Y. Komine, T. Mori, I. Matsumoto, K. Abe, I. Tokimitsu, T. Hase, and T. Murase Differential regulation of intestinal lipid metabolism-related genes in obesity-resistant A/J vs. obesity-prone C57BL/6J mice Am J Physiol Endocrinol Metab, November 1, 2006; 291(5): E1092 - E1099. [Abstract] [Full Text] [PDF]

				T. L. McIlhargey, Y. Yang, H. Wong, and J. S. Hill Identification of a Lipoprotein Lipase Cofactor-binding Site by Chemical Cross-linking and Transfer of Apolipoprotein C-II-responsive Lipolysis from Lipoprotein Lipase to Hepatic Lipase J. Biol. Chem., June 13, 2003; 278(25): 23027 - 23035. [Abstract] [Full Text] [PDF]

				L. C. Wilsie and R. A. Orlando The Low Density Lipoprotein Receptor-related Protein Complexes with Cell Surface Heparan Sulfate Proteoglycans to Regulate Proteoglycan-mediated Lipoprotein Catabolism J. Biol. Chem., April 25, 2003; 278(18): 15758 - 15764. [Abstract] [Full Text] [PDF]

				Y. Shen, A. Lookene, S. Nilsson, and G. Olivecrona Functional Analyses of Human Apolipoprotein CII by Site-directed Mutagenesis. IDENTIFICATION OF RESIDUES IMPORTANT FOR ACTIVATION OF LIPOPROTEIN LIPASE J. Biol. Chem., February 1, 2002; 277(6): 4334 - 4342. [Abstract] [Full Text] [PDF]

				M. Dahim, W. E. Momsen, M. M. Momsen, and H. L. Brockman Specificity of the lipid-binding domain of apoC-II for the substrates and products of lipolysis J. Lipid Res., April 1, 2001; 42(4): 553 - 562. [Abstract] [Full Text]

				P. Fornengo, A. Bruno, R. Gambino, M. Cassader, and G. Pagano Resistant Hypertriglyceridemia in a Patient With High Plasma Levels of Apolipoprotein CII Arterioscler Thromb Vasc Biol, October 1, 2000; 20(10): 2329 - 2339. [Full Text] [PDF]

				M. C. Jong, M. H. Hofker, and L. M. Havekes Role of ApoCs in Lipoprotein Metabolism : Functional Differences Between ApoC1, ApoC2, and ApoC3 Arterioscler Thromb Vasc Biol, March 1, 1999; 19(3): 472 - 484. [Full Text] [PDF]